Why Ironwood Pharmaceuticals, Inc. (IRWD) stock rose 9.7% intraday on Thursday, November 5, 2026

Ironwood Pharmaceuticals, Inc. (IRWD) traded at $4.14 as of 10:31 AM ET, up 9.68% on Thursday, November 5, 2026, on volume of 1,661,735 shares (0.9× its 3-month average); market value about $700.0M.

IRWD was among the stocks moving 5% or more in an earlier update that day; by the close it was no longer moving that much.

What happened: primary sources

Events Nexqual found for IRWD on Thursday, November 5, 2026 or the trading day before (November 4, 2026):

• Nov 5, 2026: Reported Q3 2026 results: adjusted EPS $0.36 vs consensus $0.31 (beat), revenue $133.0M vs consensus $121.6M (beat). Guidance: Raises full-year 2026 total revenue guidance to $485 - $510 million. source
• Nov 5, 2026: One of 3 Drug Manufacturers - Specialty & Generic stocks among the day's biggest gainers (IRWD, COLL, CRON), with no comparable group among the biggest losers

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on IRWD

IRWD stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Earnings report: IRWD results, November 5, 2026. Other big moves that day: November 5, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:39 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 10, 2026 at 16:39 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt